US Bancorp
CRBP icon

US Bancorp’s Corbus Pharmaceuticals CRBP Stock Holding History

US Bancorp’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7
Closed – – 3886
2020
Q4 		$0 Sell
7
-4
-36% -$150 ﹤0.01% 3775
2020
Q3 		$1K Buy
11
+6
+120% +$1.09K ﹤0.01% 3567
2020
Q2 		$1K Buy
+5
New +$1.01K ﹤0.01% 3583
2018
Q2 		– Sell
-50
Closed -$9K – 3615
2018
Q1 		$9K Buy
50
+23
+85% +$5.17K ﹤0.01% 3172
2017
Q4 		$6K Hold
27
– – ﹤0.01% 3273
2017
Q3 		$6K Hold
27
– – ﹤0.01% 3203
2017
Q2 		$5K Hold
27
– – ﹤0.01% 3208
2017
Q1 		$7K Buy
+27
New +$6.63K ﹤0.01% 3120

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

US Bancorp's CRBP Position: Q1 2021 in Review

US Bancorp sold out of Corbus Pharmaceuticals (CRBP) in Q1 2021, closing a stake of 7 shares.

US Bancorp first reported a position in CRBP in Q1 2017 and held it in 8 quarters. The position peaked at $9K in Q1 2018. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2021.

  • US Bancorp reported no remaining Corbus Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • US Bancorp sold 7 Corbus Pharmaceuticals shares in Q1 2021.
  • US Bancorp first reported a position in Corbus Pharmaceuticals in Q1 2017 and held it in 8 quarters.
  • US Bancorp's Corbus Pharmaceuticals position peaked at $9K in Q1 2018.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2021.

Based on US Bancorp's 13F filing for Q1 2021, filed 28 Apr 2021.